Skip to main content

Table 3 Total and separate cell percentage and counts in peripherial blood and BAL fluid

From: Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease

Variable Lung cancer group Control group
Without COPD With COPD COPD Healthy individuals
Peripheral blood cells, mean ± SEM:     
Leukocytes, x109l 8.57 ± 0.25*§ 8.71 ± 0.48*§ 5.81 ± 0.13* 5.35 ± 0.17
Neutrophils, % 65.34 ± 0.85*§ 67.45 ± 1.43*§ 61.77 ± 1.18* 56.92 ± 1.65
Neutrophils, x109l 5.72 ± 0.22*§ 5.96 ± 0.39*§ 4.35 ± 0.22* 3.70 ± 0.25
Lymphocytes, % 23.01 ± 0.79*§ 21.11 ± 1.21*§ 25.93 ± 0.99* 31.64 ± 1.45
Lymphocytes, x109l 1.88 ± 0.06 1.84 ± 0.10 1.78 ± 0.09 1.99 ± 0.09
Monocytes, % 8.60 ± 0.30*§ 8.10 ± 0.49*§ 6.82 ± 0.29 6.26 ± 0.42
Monocytes, x109l 0.87 ± 0.09*§ 0.88 ± 0.17*§ 0.46 ± 0.03 0.40 ± 0.03
Neutrophil/lymphocyte ratio, median (range) 2.92(0.93–13.42)*§ 3.08(1.18–8.84)* § 2.35(1.13–4.25)§ 1.86(1.16–3.21)
BAL fluid cells, mean ± SEM:     
Neutrophils, % 8.01 ± 1.37*§ 7.94 ± 0.83*§ 14.10 ± 2.96* 1.29 ± 0.21
Neutrophils, x106/ml 0.39 ± 0.12*§ 0.41 ± 0.15*§ 0.54 ± 0.22* 0.08 ± 0.05
Macrophages, % 73.59 ± 1.51§ 72.89 ± 1.71§ 65.50 ± 3.19* 74.40 ± 1.77
Macrophages, x106/ml 3.24 ± 0.20§ 3.15 ± 0.30§ 2.95 ± 0.65* 3.21 ± 0.51
Lymphocytes, % 18.21 ± 1.02 18.81 ± 1.48 19.99 ± 1.80 21.97 ± 1.62
Lymphocytes, x106/ml 0.87 ± 0.34 1.03 ± 0.37 1.11 ± 0.53 0.63 ± 0.26
Eosinophils, % 0.29 ± 0.04 0.36 ± 0.06 0.41 ± 0.15 0.34 ± 0.11
Eosinophils, x106/ml 0.02 ± 0.01 0.01 ± 0.01 0.03 ± 0.01 0.02 ± 0.01
  1. Data are expressed as mean ± SEM. *P < 0.05 when compared with healthy individuals; §P < 0.05 when compared to COPD group.